Wolfram Syndrome: Only a Neurodegenerative Disease or Also a Maculopathy?
- PMID: 37581949
- DOI: 10.1097/WNO.0000000000001981
Wolfram Syndrome: Only a Neurodegenerative Disease or Also a Maculopathy?
Conflict of interest statement
E. Borrelli is a consultant/advisor for: AbbVie, Apellis, Bayer Shering-Pharma, Hoffmann-La-Roche, Zeiss. F. Bandello is a consultant for: AbbVie, Alimera Sciences, Bayer Shering-Pharma, Boehringer-Ingelheim, Fidia Sooft, Hoffmann-La-Roche, Novartis, NTC Pharma, Oxurion NV, SIFI. All other authors report no conflicts of interest.
References
-
- Chau TTH, Bertrand D, Bruno D. Pigmentary maculopathy in two siblings with Wolfram syndrome. Retin Cases Br Rep. 2010;4:150–153.
-
- Majander A, Chan CM, Duncan HJ, Chinnery PF, Subash M. Europe PMC funders group lamination of the outer plexiform layer in optic atrophy caused by dominant WFS1 mutations. 2019;123:1624–1626.
-
- Schmidt-Kastner R, Kreczmanski P, Preising M, et al. Expression of the diabetes risk gene wolframin (WFS1) in the human retina. Exp Eye Res. 2009;89:568–574.
-
- Gunzinger JM, Fasler K, Barthelmes D, et al. En face optical coherence tomography imaging ellipsoid zone regeneration in laser-induced and solar maculopathies. Case Rep Ophthalmol Med. 2019;2019:3849871.
-
- Van Bol LB, Kurt RA, Keane PA, Pal B, Sivaprasad S. Clinical phenotypes of poppers maculopathy and their links to visual and anatomic recovery. Ophthalmology. 2017;124:1425–1427.
LinkOut - more resources
Full Text Sources
